MedTrace Logo

Infants Fed a Hydrolyzed Infant Formula

NCT05369494 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2024-05-01

No results posted yet for this study

Summary

The purpose of this non-randomized, multi-center study is to evaluate the growth, tolerance and compliance of an extensively hydrolyzed infant formula in an intended use population of infants.

Conditions

  • Gastrointestinal Tolerance

Interventions

OTHER

Hydrolyzed protein infant formula with oligosaccharides

Hydrolyzed protein infant formula with oligosaccharides

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Carlett Ramirez · Abbott Nutrition

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
0 Days
Max Age
90 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-07
Primary Completion
2023-06-23
Completion
2023-11-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05369494 on ClinicalTrials.gov